Francesco Lauria
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.
Journal: Blood
Published: January 05, 2026
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Journal: Leukemia
Published: December 04, 2023
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Journal: Blood cancer journal
Published: September 18, 2022
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
Journal: Leukemia
Published: February 26, 2021
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
Journal: Annals of hematology
Published: August 24, 2017
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Journal: Blood
Published: January 21, 2016
Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.
Journal: Leukemia research
Published: February 05, 2014
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Journal: American journal of hematology
Published: December 18, 2013
Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.
Journal: Tumori
Published: December 12, 2013
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients.
Journal: Leukemia research and treatment
Published: September 30, 2011
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
Journal: Cancer
Published: September 29, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026